Loading...
Please wait, while we are loading the content...
Similar Documents
Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
| Content Provider | MDPI |
|---|---|
| Author | Norman, Gary L. Navaz, Sherwin A. Kanthi, Yogendra Albesa, Roger Mahler, Michael Knight, Jason S. Zuo, Yu |
| Copyright Year | 2022 |
| Description | Background: New tools for the assessment and prediction of the severity of hospitalized COVID-19 patients can help direct limited resources to patients with the greatest need. Circulating levels of calprotectin (S100A8/S100A9) reflect inflammatory activity in multiple conditions, and have been described as being elevated in COVID-19 patients, but their measurement is not routinely utilized. The aim of our study was to assess the practical and predictive value of measuring circulating calprotectin levels in patients at admission and during their hospitalization. Methods: Circulating calprotectin levels were measured in 157 hospitalized patients with COVID-19 using an automated quantitative chemiluminescent assay. Results: Circulating calprotectin levels were strongly correlated with changing respiratory supplementation needs of patients. The overall trajectory of circulating calprotectin levels generally correlated with patient improvement or deterioration. Conclusions: Routine measurement of circulating calprotectin levels may offer a valuable tool to assess and monitor hospitalized patients with COVID-19, as well as other acute inflammatory conditions. |
| Starting Page | 1324 |
| e-ISSN | 20754418 |
| DOI | 10.3390/diagnostics12061324 |
| Journal | Diagnostics |
| Issue Number | 6 |
| Volume Number | 12 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-05-27 |
| Access Restriction | Open |
| Subject Keyword | Diagnostics Womens Studies Calprotectin Serum Biomarker Covid-19 Sars-cov-2 Severity Predictive Chemiluminescent Immunoassay S100a8/s100a9 |
| Content Type | Text |
| Resource Type | Article |